Candesartan
Links shared publicly online about this topic
Pulse - Candesartan better than amlodipine in hypertension
pulsetoday.co.uk — “Pulse - Candesartan better than amlodipine in hypertension” View full resource at pulsetoday.co.uk
Most Recently Shared on April 21, 2010 at 10:49 am By:
PulseToday Health News and Medical Publisher
Candesartan better than amlodipine in hypertension: Candesartan has a greater effect on reducing the risk of new-o... http://bit.ly/djIdwM
Amias (candesartan) for Chronic Heart Failure | Pumping Marvellous
pumpingmarvellous.com — “Good news for Heart Failure patients who can't tolerate ACE inhibitors. Takeda has highlighted a new ruling by the National Institute for Health and Clinical Excellence NICE” View full resource at pumpingmarvellous.com
Most Recently Shared on October 28, 2010 at 11:24 am By:
Missed Post - Amias (candesartan) for Chronic Heart Failure - http://bit.ly/dzKABD
Symposier - Candesartan Didn't Improve Stroke Outcomes
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews --" Patients who received candesartan or placebo within the first week after a stroke had virtually the same cardiovascular, clinical, and functional outcomes 6 months later, explains Dr. Eivind Berge. See the related story at http://tinyurl.com/6dezbm4” View full resource at symposier.com
Most Recently Shared on March 9, 2011 at 12:16 am By:
Symposier Cardiology Cardiology and Health Business
Candesartan Didn't Improve Stroke Outcomes, SCAST study finds no difference between drug and placebo. http://bit.ly/evFYHK
Uremic Frost: MedPage: Survival Benefit for Candesartan
uremicfrost.com — “The Nephrology Blog” View full resource at uremicfrost.com
Most Recently Shared on June 1, 2010 at 7:12 pm By:
Uremic Frost: MedPage: Survival Benefit for Candesartan http://bit.ly/9lsG12
China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug
medicalnewstoday.com — “China Pharma Holdings, Inc. (China Pharma) (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, announced that the Company has completed clini” View full resource at medicalnewstoday.com
Most Recently Shared on January 23, 2010 at 4:04 pm By:
MNT Clinical Trials Health News
China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug http://mnt.to/3wHH #clinicaltrials
The Effect of Chronic Candesartan Therapy on the Metabolic Profile and Renal Tissue Cytokine Levels in the Obese Zucker Rat
hindawi.com — “The effect of candesartan, an angiotensin-II type-1 receptor antagonist, on the metabolic profile and renal inflammation is unclear. We evaluated this relationship by feeding male lean (LZ) and obese (OZ) Zucker rats chow or chow with candesartan (23.5mg/) for 14 weeks ("8/treatment/body type). Candesartan reduced serum triglycerides, plasma creatinine, urine albumin, and renal cortical collagen and glycogen deposition in the OZ. An ELISA-based cytokine array revealed that candesartan normalized” View full resource at hindawi.com
Most Recently Shared on May 17, 2010 at 6:09 pm By:
The Effect of Chronic Candesartan Therapy on the Metabolic Profile and Renal Tissue Cytokine Levels in the Obese Z... http://bit.ly/ao8FDn
Candesartan is not beneficial in patients with acute stroke and high blood pressure, and may actually be harmful
eurekalert.org — “Using the blood pressure-lowering drug candesartan in patients who have high blood pressure in the acute phase of stroke does not give any benefit, and may actually be harmful.” View full resource at eurekalert.org
Most Recently Shared on February 11, 2011 at 8:00 pm By:
Candesartan is not beneficial in patients with acute #stroke and high blood pressure http://eurekalert.org/e/3tng @thelancetmedicaljournal
Candesartan Added to Amlodipine Helps Hypertensive CAD Patients - QualityPoint Technologies
qualitypointtech.net — “Rates of major adverse cardiovascular events (MACEs) are lower in hypertensive patients with coronary artery disease (CAD) on amlodipine when candesartan is added to their treatment, a Japanese trial shows. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on August 16, 2010 at 10:30 pm By:
Candesartan Added to Amlodipine Helps Hypertensive CAD Patients: Rates of major adverse cardiovascular events (MAC... http://bit.ly/9AThhr
Medical News: HFC: Registry Data Suggest Survival Benefit for Candesartan - in Meeting Coverage, HFC from MedPage Today
medpagetoday.com — “BERLIN -- Systolic heart failure patients treated with candesartan (Atacand) had better one-year survival than those taking losartan (Cozaar) -- regardless of dose, comorbidities, or background heart” View full resource at medpagetoday.com
Most Recently Shared on May 31, 2010 at 10:16 am By:
HFC: Registry Data Suggest Survival Benefit for Candesartan (CME/CE) http://ow.ly/17yPgv
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial : The Lancet
thelancet.com — “The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. By - Else Charlotte Sandset MD, Prof Philip MW Bath FRCP, P...” View full resource at thelancet.com
Most Recently Shared on February 26, 2011 at 2:14 am By:
[Articles] The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, pla... http://bit.ly/hQyTP8
Medical News: HFC: Registry Data Suggest Survival Benefit for Candesartan - in Meeting Coverage, HFC from MedPage Today
medpagetoday.com — “BERLIN -- Systolic heart failure patients treated with candesartan (Atacand) had better one-year survival than those taking losartan (Cozaar) -- regardless of dose, comorbidities, or background heart” View full resource at medpagetoday.com
Most Recently Shared on May 31, 2010 at 2:43 am By:
Patricia Grace Eldercare Expert
HFC: Registry Data Suggest Survival Benefit for Candesartan (CME/CE): BERLIN (MedPage Today) -- Systolic heart fai... http://bit.ly/cdVbqJ
Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure, January 12, 2011, Eklind-Cervenka et al. 305 (2): 175 --" JAMA
jama.ama-assn.org — “Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure, January 12, 2011, Eklind-Cervenka et al. 305 (2): 175 --" JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on January 12, 2011 at 10:33 pm By:
Sandeep Pulim Health Communicator, Physician, and Doctor
Among Heart Failure Registry pts the use of candesartan compared w/ losartan was associated w/ a lower mortality risk http://bit.ly/gpSEJA
Comparison of Medications for Heart Failure Finds Difference in Risk of Death - Drugs.com MedNews
drugs.com — “CHICAGO In a comparison of the angiotensin II receptor blockers (ARBs) candesartan and losartan, used by patients with heart failure, candesartan was associated” View full resource at drugs.com
Most Recently Shared on January 12, 2011 at 3:09 pm By:
Drugs and Devices OW OW Health
Comparison of Medications for Heart Failure Finds Difference in Risk of Death: CHICAGO—In a comparison of ... http://bit.ly/gaooTQ #drug
Comparison Of Medications For Heart Failure Finds Difference In Risk Of Death
medicalnewstoday.com — “In a comparison of the angiotensin II receptor blockers (ARBs) candesartan and losartan, used by patients with heart failure, candesartan was associated with a lower risk of death at 1 and 5 years” View full resource at medicalnewstoday.com
Most Recently Shared on January 12, 2011 at 12:56 pm By:
MedicalNewsToday: Comparison Of Medications For Heart Failure Finds Difference In Risk Of: http://bit.ly/fcsPQK Full http://bit.ly/dHMN5g
Not All Heart Failure Drugs Boost Survival Equally - Drugs.com MedNews
drugs.com — “Over the course of five years, heart failure patients taking the blood pressure drug candesartan stood a higher chance of survival than those taking losartan di” View full resource at drugs.com
Most Recently Shared on January 11, 2011 at 10:02 pm By:
Drugs and Devices OW OW Health
Not All Heart Failure Drugs Boost Survival Equally: TUESDAY, Jan. 11 -- Over the course of five years, hea... http://bit.ly/gVl0bT #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
PulseToday
PulseToday.co.uk - Medical news, views, education and clinical information to GPs, nurses and other health professionals.
-
Pumping Marvellous
Education and dialogue about heart failure - run by Heart Failure Patients for Heart Failure Patients from the East Lancs PCT
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
Advertisement
